These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11752538)

  • 1. Breakthrough of the year. The runners-up.
    Science; 2001 Dec; 294(5551):2443-7. PubMed ID: 11752538
    [No Abstract]   [Full Text] [Related]  

  • 2. [Targeted therapy with imatinib has reformed the treatment of chronic myeloid leukemia].
    Nielsen JL
    Ugeskr Laeger; 2003 May; 165(20):2111. PubMed ID: 12812107
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML.
    Druker BJ
    Oncogene; 2002 Dec; 21(56):8541-6. PubMed ID: 12476300
    [No Abstract]   [Full Text] [Related]  

  • 4. An 85-year-old Japanese woman with Philadelphia chromosome-positive chronic myelogenous leukemia with del (5q) successfully treated by intermittent imatinib therapy.
    Maeda T; Mutoh T; Muta H; Nakayama M; Nakajima Y; Ikuta T; Yasuda M; Etoh T; Shimizu K; Nakazaki Y; Hiroyama T; Somada S; Kurita R; Tani K; Shiratsuchi M; Nishimura J
    J Am Geriatr Soc; 2004 Oct; 52(10):1783-4. PubMed ID: 15450069
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction: chronic myelogenous leukemia (CML).
    Jabbour E; Kantarjian H
    Semin Hematol; 2007 Jan; 44(1 Suppl 1):S1-3. PubMed ID: 17292735
    [No Abstract]   [Full Text] [Related]  

  • 6. Trisomy 8 finding treatment of imatinib mesylate in chronic myeloid leukemia cases.
    Tunca Y; Güran S
    Exp Hematol; 2005 Feb; 33(2):151. PubMed ID: 15676207
    [No Abstract]   [Full Text] [Related]  

  • 7. [Attentive questions about treatment of chronic myelogenous leukemia with imatinib mesylate].
    Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):433-5. PubMed ID: 17147242
    [No Abstract]   [Full Text] [Related]  

  • 8. Unable to resist.
    Brooksbank C
    Nat Rev Cancer; 2002 Apr; 2(4):248. PubMed ID: 12001985
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of conjunctival chemosis secondary to imatinib treatment for chronic myelogenous leukemia.
    Jin J; Chen H; Cao L
    Leuk Res; 2009 Jun; 33(6):e18-9. PubMed ID: 19108890
    [No Abstract]   [Full Text] [Related]  

  • 10. Antituberculosis therapy and imatinib for chronic myeloid leukemia.
    Sorà F; De Matteis S; Di Mario A; Maiuro G; Laurenti L; Chiusolo P; Ardito F; Leone G; Sica S
    Clin Infect Dis; 2006 Nov; 43(9):1224. PubMed ID: 17029152
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of imatinib mesylate in a 15-month old with Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia.
    Richardson MW; Grewal SS
    Pediatr Blood Cancer; 2008 Jan; 50(1):186. PubMed ID: 17455313
    [No Abstract]   [Full Text] [Related]  

  • 12. Complete response to imatinib mesylate treatment in a 12-month-old patient with chronic myeloid leukemia.
    Arancibia AM; Bendit I; Epelman S
    Pediatr Blood Cancer; 2008 May; 50(5):1078. PubMed ID: 18085674
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful imatinib mesylate therapy for acquired von Willebrand syndrome in chronic myelogenous leukemia.
    Uchiyama M; Ikeda T
    Leuk Res; 2009 Dec; 33(12):1723-4. PubMed ID: 19580999
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA approves Gleevec for pediatric leukemia.
    FDA Consum; 2003; 37(4):6. PubMed ID: 12971334
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic myeloid leukemia and imatinib mesylate therapy].
    Chrobák L
    Vnitr Lek; 2004 Jan; 50(1):10-2. PubMed ID: 15015223
    [No Abstract]   [Full Text] [Related]  

  • 16. [Imatinib--en epoch-making new drug against chronic myeloid leukemia].
    Lakartidningen; 2003 Jun; 100(26-27):2283. PubMed ID: 12872372
    [No Abstract]   [Full Text] [Related]  

  • 17. [Imatinib. An anticancer agents indicated in the treatment of chronic myeloid leukemia]].
    Taéron C
    Rev Infirm; 2004 Feb; (98):39-40. PubMed ID: 15042992
    [No Abstract]   [Full Text] [Related]  

  • 18. [Molecular therapy of chronic myeloid leukemia--a new era in the treatment of malignant diseases].
    Deininger M; Niederwieser D
    Med Klin (Munich); 2002 Jan; 97 Suppl 1():1. PubMed ID: 11831065
    [No Abstract]   [Full Text] [Related]  

  • 19. Promyelocytic blast crisis of chronic myelogenous leukemia during imatinib treatment.
    Gozzetti A; Bocchia M; Calabrese S; Pirrotta MT; Crupi R; Raspadori D; Lauria F
    Acta Haematol; 2007; 117(4):236-7. PubMed ID: 17308370
    [No Abstract]   [Full Text] [Related]  

  • 20. Update on the use of imatinib mesylate.
    Sawyers CL
    Clin Adv Hematol Oncol; 2005 Oct; 3(10):757-8. PubMed ID: 16258483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.